Intravenous Magnesium for Neuroprotection in Acute Stroke: Clinical Hope Versus Basic Neuropharmacology

Formulation and evaluation of magnesium sulphate nanoparticles for improved CNS penetrability

Magnesium (Mg²⁺) is the fourth most abundant cation in the human body and is involved in maintaining varieties of cellular and neurological functions. Magnesium deficiency has been associated with numerous diseases, particularly neurological disorders, and its supplementation has proven beneficial. However, magnesium therapy in neurological diseases is limited because of the inability of magnesium to cross the blood-brain barrier (BBB). The present study focuses on developing magnesium sulphate nanoparticles (MGSN) to improve blood-brain barrier permeability. MGSN was prepared by precipitation technique with probe sonication. The developed formulation was characterized by DLS, EDAX, FT-IR and quantitative and qualitative estimation of magnesium. According to the DLS report, the average size of the prepared MGSN is found to be 247 nm. The haemocompatibility assay studies revealed that the prepared MGSN are biocompatible at different concentrations. The in vitro BBB permeability assay conducted by Parallel Artificial Membrane Permeability Assay (PAMPA) using rat brain tissue revealed that the prepared MGSN exhibited enhanced BBB permeability as compared to the marketed i.v. MgSO₄ injection. The reversal effect of MGSN to digoxin-induced Na⁺/K⁺ ATPase enzyme inhibition using brain microslices confirmed that MGSN could attenuate the altered levels of Na⁺ and K⁺ and is useful in treating neurological diseases with altered expression of Na⁺/K⁺ ATPase activity.

Magnesium-based biodegradable microelectrodes for neural recording

This article reports fabrication, characterization, degradation and electrical properties of biodegradable magnesium (Mg) microwires coated with two functional polymers, and the first in vivo evidence on the feasibility of Mg-based biodegradable microelectrodes for neural recording. Conductive poly(3,4‑ethylenedioxythiophene) (PEDOT) coating was first electrochemically deposited onto Mg microwire surface, and insulating biodegradable poly(glycerol sebacate) (PGS) was then spray-coated onto PEDOT surface to improve the overall properties of microelectrode. The assembled PGS/PEDOT-coated Mg microelectrodes showed high homogeneity in coating thickness, surface morphology and composition before and after in vivo recording. The charge storage capacity (CSC) of PGS/PEDOT-coated Mg microwire (1.72 mC/cm²) was nearly 5 times higher than the standard platinum (Pt) microwire widely used in implantable electrodes. The Mg-based microelectrode demonstrated excellent neural-recording capability and stability during in vivo multi-unit neural recordings in the auditory cortex of a mouse. Specifically, the Mg-based electrode showed clear and stable onset response, and excellent signal-to-noise ratio during spontaneous-activity recordings and three repeats of stimulus-evoked recordings at two different anatomical locations in the auditory cortex. During 10 days of immersion in artificial cerebrospinal fluid (aCSF) in vitro, PGS/PEDOT-coated Mg microelectrodes showed slower degradation and less change in impedance than PEDOT-coated Mg electrodes. The biodegradable PGS coating protected the PEDOT coating from delamination, and prolonged the mechanical integrity and electrical properties of Mg-based microelectrode. Mg-based novel microelectrodes should be further studied toward clinical translation because they can potentially eliminate the risks and costs associated with secondary surgeries for removal of failed or no longer needed electrodes.

Electrochemical deposition of conductive polymers onto magnesium microwires for neural electrode applications

Metals are widely used in electrode design for recording neural activities because of their excellent electrical conductivity and mechanical strength. However, there are still serious problems related to these currently used metallic electrodes, including tissue damage due to the mechanical mismatch between metals and neural tissues, fibrosis, and electrode fouling and encapsulation that lead to the loss of signal and eventual failure. In this study, a biocompatible, biodegradable, and conductive electrode was created. Specifically, pure magnesium (Mg) microwire with a diameter of 127 µm was used as the electrode substrate and the conductive polymer, that is, poly(3,4-ethylenedioxythiophene) (PEDOT), was electrochemically deposited onto Mg microwires to decrease corrosion rate and improve biocompatibility of the electrodes for potential neural electrode applications. Both chronopotentiometry and cyclic voltammetry (CV) methods and the associated parameters for electrochemical deposition of PEDOT onto Mg microwires were investigated, such as deposition current, deposition temperature, voltage, sweep rate, cycle number, and duration. The CV method from -2.0 to 1.25 V for 1 cycle at a cycle duration of 600 s with a sweep rate of 5 mV/s at 65°C led to a consistent, uniform, and complete PEDOT coating on Mg microwires. The surface conditions of Mg microwires also affected the quality of PEDOT coating. The corrosion rate of PEDOT-coated Mg microwire was 0.75 mm/year, much slower than the noncoated Mg microwire that showed a corrosion rate of 1.78 mm/year. The optimal Mg microwires with PEDOT coating could potentially serve as biodegradable electrodes for neural recording and stimulation applications. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 1887-1895, 2018.

The effects of poly(3,4-ethylenedioxythiophene) coating on magnesium degradation and cytocompatibility with human embryonic stem cells for potential neural applications

Magnesium (Mg) is a promising conductive metallic biomaterial due to its desirable mechanical properties for load bearing and biodegradability in human body. Controlling the rapid degradation of Mg in physiological environment continues to be the key challenge toward clinical translation. In this study, we investigated the effects of conductive poly(3,4-ethylenedioxythiophene) (PEDOT) coating on the degradation behavior of Mg substrates and their cytocompatibility. Human embryonic stem cells (hESCs) were used as the in vitro model system to study cellular responses to Mg degradation because they are sensitive and can potentially differentiate into many cell types of interest (e.g., neurons) for regenerative medicine. The PEDOT was deposited on Mg substrates using electrochemical deposition. The greater number of cyclic voltammetry (CV) cycles yielded thicker PEDOT coatings on Mg substrates. Specifically, the coatings produced by 2, 5, and 10 CV cycles (denoted as 2×-PEDOT-Mg, 5×-PEDOT-Mg, and 10×-PEDOT-Mg) had an average thickness of 31, 63, and 78 µm, respectively. Compared with non-coated Mg samples, all PEDOT coated Mg samples showed slower degradation rates, as indicated by Tafel test results and Mg ion concentrations in the post-culture media. The 5×-PEDOT-Mg showed the best coating adhesion and slowest Mg degradation among the tested samples. Moreover, hESCs survived for the longest period when cultured with the 5×-PEDOT-Mg samples compared with the non-coated Mg and 2×-PEDOT-Mg. Overall, the results of this study showed promise in using PEDOT coating on biodegradable Mg-based implants for potential neural recording, stimulation and tissue engineering applications, thus encouraging further research.

Electrochemical deposition and evaluation of electrically conductive polymer coating on biodegradable magnesium implants for neural applications

In an attempt to develop biodegradable, mechanically strong, biocompatible, and conductive nerve guidance conduits, pure magnesium (Mg) was used as the biodegradable substrate material to provide strength while the conductive polymer, poly(3,4-ethylenedioxythiophene) (PEDOT) was used as a conductive coating material to control Mg degradation and improve cytocompatibility of Mg substrates. This study explored a series of electrochemical deposition conditions to produce a uniform, consistent PEDOT coating on large three-dimensional Mg samples. A concentration of 1 M 3,4-ethylenedioxythiophene in ionic liquid was sufficient for coating Mg samples with a size of 5 × 5 × 0.25 mm. Both cyclic voltammetry (CV) and chronoamperometry coating methods produced adequate coverage and uniform PEDOT coating. Low-cost stainless steel and copper electrodes can be used to deposit PEDOT coatings as effectively as platinum and silver/silver chloride electrodes. Five cycles of CV with the potential ranging from -0.5 to 2.0 V for 200 s per cycle were used to produce consistent coatings for further evaluation. Scanning electron micrographs showed the micro-porous structure of PEDOT coatings. Energy dispersive X-ray spectroscopy showed the peaks of sulfur, carbon, and oxygen, indicating sufficient PEDOT coating. Adhesion strength of the coating was measured using the tape test following the ASTM-D 3359 standard. The adhesion strength of PEDOT coating was within the classifications of 3B to 4B. Tafel tests of the PEDOT coated Mg showed a corrosion current (I(CORR)) of 6.14 × 10(-5) A as compared with I(CORR) of 9.08 × 10(-4) A for non-coated Mg. The calculated corrosion rate for the PEDOT coated Mg was 2.64 mm/year, much slower than 38.98 mm/year for the non-coated Mg.

Congenic removal of a QTL for blood pressure attenuates infarct size produced by middle cerebral artery occlusion in hypertensive rats

A genome-wide screen found a blood pressure quantitative trait locus (QTL) on rat chromosome 1 in stroke-prone spontaneously hypertensive rats of a Japanese colony (SHRSP/Izm). In the present study, we investigated the effects of congenic removal of this QTL from SHRSP/Izm on infarct size produced by middle cerebral artery (MCA) occlusion. To establish the congenic strain (SHRSPwch1.0), the blood pressure QTL was introgressed from Wistar-Kyoto (WKY)/Izm to SHRSP/Izm by repeated backcrossing. Male SHRSP/Izm [10-12 wk old (young adult) n = 8, 5 mo old (adult) n = 17] and SHRSPwch1.0 (young adult n = 7, adult n = 15) were randomly assigned to distal MCA occlusion. Resting mean arterial blood pressure (MABP) was 212 +/- 23 mmHg in adult SHRSPwch1.0, which was significantly lower than 241 +/- 22 mmHg in SHRSP/Izm. Infarct volume in the congenic rats was significantly decreased compared with that in SHRSP/Izm (66.4 +/- 21.5 mm(3) vs. 103.4 +/- 24.8 mm(3)). Cerebral blood flow (CBF), determined at collaterally-perfused cortex with laser-Doppler flowmetry after MCA occlusion, was significantly greater in adult SHRSPwch1.0 compared with CBF in adult SHRSP/Izm. In young adult rats, there were no significant differences in MABP or in infarct volume between SHRSPwch1.0 and SHRSP/Izm. The congenic removal of a blood pressure QTL lowered blood pressure and caused a substantial reduction in infarct volume (-36%) with increased collateral CBF after MCA occlusion in the congenic rat. We demonstrated for the first time that the congenic strategy is useful to investigate the effects of genetic hypertension on focal ischemia or stroke.